ZebiAI Therapeutics, Inc. Announces Collaboration With Google Accelerated Science to Focus on Unlocking Novel Therapeutic Targets and Transforming Small Molecule Drug Discovery

WALTHAM, Mass.--(BUSINESS WIRE)--ZebiAI Therapeutics, Inc., a privately held company, announced a multiyear service and collaboration agreement with Google Accelerated Science (GAS) (https://research.google/teams/applied-science/gas/), Mountain View, CA, focused on the application of machine learning to accelerate the identification of small molecule therapeutics. ZebiAI Therapeutics was established to apply machine learning and DEL technologies to revolutionize target and drug candidate identi

Click to view original post